✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

Avalyn seeks $300m from its IPO · NabkaNews

← Back to headlines

Avalyn seeks $300m from its IPO

pharmaphorum·Apr 30

This story is reported by pharmaphorum. Read what other outlets are saying below, then open the original report for full details.

Full coverage

IPO Tracker 2026: Cardio biotech Kardigan binds off $400M upsized IPO

BioSpace·Jun 18

Avalyn, in pursuit of better lung drugs, banks $300M in an IPO

BioPharma Dive·Apr 29

Pulmonary drug developer Avalyn surges on IPO (AVLN:NASDAQ)

Seeking Alpha·Apr 30

Chasing a tough-to-treat lung disease, Avalyn plans an IPO

BioPharma Dive·Apr 9

After raising $800M, Parabilis seeks an IPO to pursue ‘undruggable’ targets

BioPharma Dive·May 20

Two biotechs raise a combined $556M in latest spurt of IPOs

BioPharma Dive·Apr 30

Radiopharmaceutical specialist Aktis seeks an IPO

BioPharma Dive·Dec 22

Eikon, a high-profile startup led by Merck vets, seeks an IPO

BioPharma Dive·Jan 11

View original report at pharmaphorum ↗